ACS Nano · 2019 · 196 citations · 34 references
Tumor phototheranostics in the second near-infrared window (NIR-II, 1000-1700 nm) holds great promise due to high spatiotemporal precision, enhanced penetration depth, and therapeutic efficacy. However, current "always-on" NIR-II phototheranostic agents remain restricted by the inherent nonspecificity from the pseudosignal readout and undesirable treatment-related side effects. To address these challenges, herein we explore an activatable and biocompatible nanotheranostics that generates diagnostic and therapeutic effects only after specific activation and enhancement by tumor microenvironmental redox and acid while keeping silent at normal tissues. Such an intelligent "turn-on" chromogenic nanotheranostics allows in vivo nearly zero-background photoacoustic tomography (PAT) and combined effective photothermal tumor therapy (PTT) both in the NIR-II range with minimal adverse effects. In light of the high sensitivity, superior penetration depth, and biocompatibility, this stimuli-activatable NIR-II photo-nanotheranostics provides broad prospects for the investigation and intervention of deep-tissue redox and acid-associated physiological and pathological events.
34
Hematoxylin and Eosin Staining of Tissue and Cell Sections
Andrew H. Fischer, Kenneth A. Jacobson, Jack Rose et al. · Cold Spring Harbor Protocols · 2008 · 2.1K citations
Acidic extracellular microenvironment and cancer
Shigeyuki Ozawa, Chihiro Miyamoto, Yojiro Maehata et al. · Cancer Cell International · 2013 · 1.3K citations · Full text